DE69718786D1 - Benzoxazinone als dopamine -d4- rezeptor-antagonisten - Google Patents

Benzoxazinone als dopamine -d4- rezeptor-antagonisten

Info

Publication number
DE69718786D1
DE69718786D1 DE69718786T DE69718786T DE69718786D1 DE 69718786 D1 DE69718786 D1 DE 69718786D1 DE 69718786 T DE69718786 T DE 69718786T DE 69718786 T DE69718786 T DE 69718786T DE 69718786 D1 DE69718786 D1 DE 69718786D1
Authority
DE
Germany
Prior art keywords
benzoxazinone
dopamine
receptor antagonists
antagonists
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69718786T
Other languages
English (en)
Other versions
DE69718786T2 (de
Inventor
Thomas Belliotti
David Wise
Juergen Wustrow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Application granted granted Critical
Publication of DE69718786D1 publication Critical patent/DE69718786D1/de
Publication of DE69718786T2 publication Critical patent/DE69718786T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/341,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/361,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69718786T 1996-05-29 1997-05-20 Benzoxazinone als dopamine -d4- rezeptor-antagonisten Expired - Fee Related DE69718786T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1838396P 1996-05-29 1996-05-29
US4020897P 1997-03-06 1997-03-06
PCT/US1997/008524 WO1997045419A1 (en) 1996-05-29 1997-05-20 Benzoxazinone dopamine d4 receptor antagonists

Publications (2)

Publication Number Publication Date
DE69718786D1 true DE69718786D1 (de) 2003-03-06
DE69718786T2 DE69718786T2 (de) 2003-10-23

Family

ID=26691052

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69718786T Expired - Fee Related DE69718786T2 (de) 1996-05-29 1997-05-20 Benzoxazinone als dopamine -d4- rezeptor-antagonisten

Country Status (37)

Country Link
EP (1) EP0906294B1 (de)
JP (1) JP2000511534A (de)
KR (1) KR20000016151A (de)
CN (1) CN1074764C (de)
AR (1) AR008372A1 (de)
AT (1) ATE231846T1 (de)
AU (1) AU731104B2 (de)
BG (1) BG64049B1 (de)
BR (1) BR9709630A (de)
CA (1) CA2253406A1 (de)
CO (1) CO4940505A1 (de)
CZ (1) CZ384698A3 (de)
DE (1) DE69718786T2 (de)
DK (1) DK0906294T3 (de)
EA (1) EA001486B1 (de)
EE (1) EE03686B1 (de)
ES (1) ES2191180T3 (de)
GE (1) GEP20012389B (de)
HK (1) HK1019737A1 (de)
HN (1) HN1997000075A (de)
HR (1) HRP970301B1 (de)
HU (1) HUP9903758A3 (de)
ID (1) ID17266A (de)
IL (1) IL126895A (de)
NO (1) NO312296B1 (de)
NZ (1) NZ332737A (de)
PA (1) PA8431101A1 (de)
PE (1) PE69398A1 (de)
PL (1) PL330195A1 (de)
PT (1) PT906294E (de)
RO (1) RO120845B1 (de)
SI (1) SI0906294T1 (de)
SK (1) SK282703B6 (de)
SV (1) SV1997000047A (de)
TW (1) TW542833B (de)
UY (1) UY24569A1 (de)
WO (1) WO1997045419A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6177422B1 (en) 1996-05-29 2001-01-23 Warner-Lambert Company Benzoxazinone dopamine D4 receptor antagonists
GB9801392D0 (en) * 1998-01-22 1998-03-18 Smithkline Beecham Plc Novel compounds
US6291463B1 (en) 1998-06-30 2001-09-18 Neurogen Corporation 1-(Benzothiazol-2-yl)-4-(1-phenylmethyl) piperazines: dopamine receptor subtype specific ligands
US6177566B1 (en) 1998-06-30 2001-01-23 Neurogen Corporation 6-(4-arylalkylpiperazin-1-yl) benzodioxane and 6-(4-arylalkylpiperazin-1-yl) chromane derivatives: dopamine receptor subtype specific ligands
WO2000000482A1 (en) * 1998-06-30 2000-01-06 Neurogen Corporation 1-(benzothiazol-2-yl)-4-(1-phenylmethyl)piperazines: dopamine receptor subtype specific ligands
WO2000000489A2 (en) * 1998-06-30 2000-01-06 Neurogen Corporation 6-(4-arylalkylpiperazin-1-yl)benzodioxane and 6-(4-arylalkylpiperazin-1-yl)chromane derivatives: dopamine receptor subtype specific ligands
DE19844291A1 (de) * 1998-09-18 2000-03-23 Schering Ag Benzoxazin- und Benzothiazin-Derivate und deren Verwendung in Arzneimitteln
GB9912411D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
CA2426706A1 (en) * 2000-10-26 2002-05-02 Smithkline Beecham P.L.C. Benzoxazinone derivatives, their preparation and use
GB0203804D0 (en) 2002-02-18 2002-04-03 Glaxo Group Ltd Compounds
GB0209244D0 (en) * 2002-04-23 2002-06-05 Glaxo Group Ltd Compounds
GB0227240D0 (en) * 2002-11-21 2002-12-31 Glaxo Group Ltd Compounds
ES2232292B1 (es) * 2003-07-30 2006-11-01 Laboratorios Del Dr. Esteve, S.A. Compuestos sulfonamidicos derivados de benzoxazinona, su preparacion y uso como medicamentos.
CN100455573C (zh) * 2005-11-11 2009-01-28 华东理工大学 一种制备1,4-苯并噁唑嗪-3-酮化合物的微波合成方法
KR200482995Y1 (ko) 2015-08-19 2017-03-23 이현진 물 공급부를 구비하는 얼음 트레이
EP4328225A1 (de) * 2021-04-23 2024-02-28 Shanghai Hansoh Biomedical Co., Ltd. Inhibitor eines heterocyclischen derivats und herstellungsverfahren dafür und anwendung davon
WO2023207283A1 (en) * 2022-04-28 2023-11-02 Ningbo Newbay Technology Development Co., Ltd Compounds as parp1 inhibitiors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4613598A (en) * 1984-03-13 1986-09-23 Mitsubishi Chemical Industries Limited Piperazine derivatives and their acid addition salts
EP0233728A1 (de) * 1986-02-11 1987-08-26 Takeda Chemical Industries, Ltd. 1,4-Benzoxazin-Derivate, ihre Herstellung und Verwendung
CA2141791A1 (en) * 1992-08-06 1994-02-17 Geoffrey Stemp 5-(2-oxyphenyl)-pyrrole derivatives as dopamine d3 receptor antagonists

Also Published As

Publication number Publication date
SI0906294T1 (en) 2003-04-30
EA001486B1 (ru) 2001-04-23
DE69718786T2 (de) 2003-10-23
EP0906294B1 (de) 2003-01-29
HN1997000075A (es) 1997-07-30
CO4940505A1 (es) 2000-07-24
SV1997000047A (es) 1998-08-13
WO1997045419A1 (en) 1997-12-04
AU731104B2 (en) 2001-03-22
ID17266A (id) 1997-12-18
HK1019737A1 (en) 2000-02-25
HRP970301A2 (en) 1998-04-30
DK0906294T3 (da) 2003-05-05
HRP970301B1 (en) 2002-08-31
CN1219930A (zh) 1999-06-16
UY24569A1 (es) 2001-08-27
PE69398A1 (es) 1998-12-02
NO985531L (no) 1998-11-27
IL126895A (en) 2001-06-14
CN1074764C (zh) 2001-11-14
KR20000016151A (ko) 2000-03-25
EE9800417A (et) 1999-06-15
HUP9903758A2 (hu) 2000-06-28
SK282703B6 (sk) 2002-11-06
BG64049B1 (bg) 2003-11-28
BR9709630A (pt) 1999-08-10
AU3072797A (en) 1998-01-05
JP2000511534A (ja) 2000-09-05
GEP20012389B (en) 2001-03-25
BG102959A (en) 1999-08-31
PA8431101A1 (es) 2001-12-14
NO312296B1 (no) 2002-04-22
RO120845B1 (ro) 2006-08-30
CZ384698A3 (cs) 1999-03-17
ES2191180T3 (es) 2003-09-01
CA2253406A1 (en) 1997-12-04
NZ332737A (en) 2000-06-23
PT906294E (pt) 2003-06-30
EE03686B1 (et) 2002-04-15
AR008372A1 (es) 2000-01-19
ATE231846T1 (de) 2003-02-15
NO985531D0 (no) 1998-11-27
HUP9903758A3 (en) 2000-07-28
PL330195A1 (en) 1999-04-26
TW542833B (en) 2003-07-21
SK162798A3 (en) 1999-06-11
EA199800987A1 (ru) 1999-06-24
EP0906294A1 (de) 1999-04-07
IL126895A0 (en) 1999-09-22

Similar Documents

Publication Publication Date Title
ATE233260T1 (de) Muscarin-antagonisten
DE69739593D1 (de) Stickstoffhaltige heterocyclen als faktor xa-hemmer
DE69734833D1 (de) Vitronektin rezeptor antagonisten
DE69718786T2 (de) Benzoxazinone als dopamine -d4- rezeptor-antagonisten
ATE221052T1 (de) Tetrahydrochinolinderivate als eaa antagonisten
DE59813430D1 (de) Perylenhydrazidimide als Carbonylderivatisierungsreagenzien
DE69626220T2 (de) 3-azetidinylalkylpiperidine oder -pyrrolidine als tachykinin antagonisten
DE59808461D1 (de) Oxazolidinone als 5-ht2a-antagonisten
DE69735811D1 (de) Piperazinoderivate als neurokinin-antagonisten
ATE232869T1 (de) Tricyclische delta3-piperidine als alpha2- antagonisten
DK0829393T3 (da) Brystningsliste
ATE275146T1 (de) Substituierte pyrazol-3-ylbenzazole
ATE208764T1 (de) Isazole derivate als fibrinogen-rezeptor- antagonisten
ID26508A (id) Oksim-oksim tersubstitusi sebagai antagonis-antagonis neurokinin
DE69714019T2 (de) 1,4-dihydropyridin-verbindungen als bradykinin-antagonisten
DE69936219D1 (de) Benzothienoä3,2-cüpyridine als alpha2-antagonisten
DE29620584U1 (de) Integrierte Arbeitseinheit
DE69809891T2 (de) Nitro-benzamid verwendbar als antiarrythmica
ID17945A (id) Lemari es
ATE223380T1 (de) Heteroaryloxyethylaminen als 5-ht1a rezeptor liganden
DE29612356U1 (de) Multifunktionsset
FR2754153B1 (fr) Etui portable de limonadier
FI2686U1 (fi) Telinerakenne
TR199601082A3 (tr) Entegrin reseptör antagonistleri.
NO962554D0 (no) Anleggsmaskin

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee